Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Acute Heart Failure (AHF) Market Research Report 2016

Tuesday, November 15, 2016 21:10
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Global Acute heart failure (AHF) Market

The Acute heart failure (AHF) – Market Insights, Epidemiology and Market Forecast-2022 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. According to DelveInsight, the global AHF market was $188 million in 2015 and expected to grow to $929 million by 2020 with and compound annual growth rate (CAGR) of 17%. 

Try Sample Report @ https://www.wiseguyreports.com/sample-request/476531-acute-heart-failure-ahf-market-insights-epidemiology-and-market-forecast-2022

Acute Heart Failure (AHF) is the rapid onset of sign and symptoms of Heart Failure resulting in need and urgent therapy or hospitalization. The AHF primarily includes the symptoms of pulmonary congestion or peripheral perfusion due to cardiac or vascular dysfunction. Based on the recommended guidelines, loop diuretics are the most common treatment for the Acute Heart Failure in patients with dyspnoea caused by pulmonary oedema, more than 90% of patients admitted with AHF receives this drug. 

Key Coverage and Benefits:

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Acute heart failure (AHF) market. 
    • Identifying patient populations in the global Acute heart failure (AHF) market to improve product design, pricing, and launch plans. 
    • Organize sales and marketing efforts by identifying the best opportunities for Acute heart failure (AHF) therapeutics in each of the markets covered. 
    • To understand the future market competition in the global Acute heart failure (AHF) therapeutics market and Insightful review of the key market drivers and barriers. 

Access Complete Report @ https://www.wiseguyreports.com/reports/476531-acute-heart-failure-ahf-market-insights-epidemiology-and-market-forecast-2022

 Scope of the Report: 

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. 
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2022. 
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2015-2022. 
• It also provides Acute heart failure (AHF) for United States, EU5 and Japan from 2015 and forecasted Market to 2022.

Table of Contents 
Report Introduction 
Executive Summary 
Key findings 
Acute Heart Failure Market Overview at a Glance 
Worldwide Market Size of Acute Heart Failure in 2015 (MM) 
Worldwide Market Size of Acute Heart Failure in 2022 (MM) 
Acute Heart Failure 
Disease Overview 
Treatment Goals 
Management 
Treatment Algorithms 
Epidemiology and Patient Population 
Key Findings 
Overview 
Diagnosed Hospitalization Cases of Acute Heart Failure 
United States 
5EU and Japan 
Total number of Hospitalization Cases for Acute Heart Failure in 7 Major Markets 
Current Clinical Practice 
Conventional Therapies for Acute Heart Failure Management 
In Cases of Pulmonary Oedema 
In cases of Hypotension and Cardiogenic Shock 
In case of Hypertension 
Treatment after Stabilization 
Acute Novel Therapies 
Carperitide 
Product Profile 
Advantages & Disadvantages 
Cost of Therapy 
Drug Sales 
Carperitide Historical Sales and Forecasted Sales (2015-2022) 
Acute Heart Failure-Global Market Assessment 
Key Findings 
Global Acute Heart Failure Market 
Market Overview 
Global Market Sales by Treatment Setting in AHF, 2015-2022 
Total Acute Heart Failure Drug Sales 
Timeline of Key Market events for Acute Heart Failure 
Acute Heart Failure-United States Market Assessment 
US Market Overview 
United States Market Sales by Treatment Setting in AHF, 2015-2022 
United States Market Share by Treatment Setting in AHF, 2015-2022 
Acute Heart Failure-France Market Assessment 
France Market Overview 
France Market Sales by Treatment Setting in AHF, 2015-2022 
France Market Share by Treatment Setting in AHF, 2015-2022 
Acute Heart Failure-Germany Market Assessment 
Germany Market Overview 
Germany Market Sales by Treatment Setting in AHF, 2015-2022 
Germany Market Share by Treatment Setting in AHF, 2015-2022 
Acute Heart Failure-Italy Market Assessment 
Italy Market Overview 
Italy Market Sales by Treatment Setting in AHF, 2015-2022 
Italy Market Share by Treatment Setting in AHF, 2015-2022 
Acute Heart Failure-Spain Market Assessment 
Spain Market Overview 
Spain Market Sales by Treatment Setting in AHF, 2015-2022 
Spain Market Share by Treatment Setting in AHF, 2015-2022 
Acute Heart Failure-United Kingdom Market Assessment 
United Kingdom Market Overview 
United Kingdom Market Sales by Treatment Setting in AHF, 2015-2022 
United Kingdom Market Share by Treatment Setting in AHF, 2015-2022 
Acute Heart Failure-Japan Market Assessment 
Japan Market Overview 
Japan Market Sales by Treatment Setting in AHF, 2015-2022 
Japan Market Share by Treatment Setting in AHF, 2015-2022 
Market Drivers and Market Constraints 
Factors driving the market for Acute Heart Failure 
Factors constraining the market for Acute Heart Failure 
Emerging Therapies 
Key findings 
Unmet Need 
Pipeline Overview 
Product Profiles (Phase III) 
Ularitide: Cardiorentis 
Product Description: 
Research and Development 
Product Development Activities: 
Serelaxin: Novartis Pharmaceuticals 
Product Description: 
Research and Development 
Product Development Activities: 
Product Profiles (Phase II) 
CXL 1427: Bristol-Myers Squibb 
Product Description: 
Research and Development 
Product Development Activities: 
TRV 027: Trevena 
Product Description: 
Research and Development 
Product Development Activities: 
Omecamtiv mecarbil: Amgen 
Product Description: 
Research and Development 
Product Development Activities: 
Post Acute Heart Failure Management Therapy 
Cenderitide: Capricor Therapeutics 
Product Description: 
Research and Development 
Product Development Activities: 
Side Effects associated with the Emereging Therapies 
Forecasting Outlook 
Global Market size of Acute Heart Failure 
Global Acute Heart Failure Therapy Sales 
Dosage, Days of Therapy and Compliance 
Prices Sources & Assumptions 
Consulting Services 
Disclaimer 
About DelveInsight

List of Tables 

Table 1: Global (7MM) Epidemiology (N) 
Table 2: Total Hospitalizations for Acute HF (Men and Women ≥45 Years) (2015-2022) 
Table 3: Carperitide Historical Sales and Forecasted Sales (2015-2022) (USD MM) 
Table 4: Global Acute Heart Failure Sales- 2015-2022 (USD MM) 
Table 5: AHF Total Therapy Sales by Treatment Setting- 2015-2022 (USD MM) 
Table 6: Timeline of Key Events in Acute Heart Failure 
Table 7: United States Acute Heart Failure Sales- 2015-2022 (USD MM) 
Table 8: AHF United States Therapy Sales by Treatment Setting- 2015-2022 (USD MM) 
Table 9: France Acute Heart Failure Sales- 2015-2022 (USD MM) 
Table 10: AHF France Therapy Sales by Treatment Setting- 2015-2022 (USD MM) 
Table 11: Germany Acute Heart Failure Sales- 2015-2022 (USD MM) 
Table 12: AHF Germany Therapy Sales by Treatment Setting- 2015-2022 (USD MM) 
Table 13: Italy Acute Heart Failure Sales- 2015-2022 (USD MM) 
Table 14: AHF Italy Therapy Sales by Treatment Setting- 2015-2022 (USD MM) 
Table 15: Spain Acute Heart Failure Sales- 2015-2022 (USD MM) 
Table 16: AHF Spain Therapy Sales by Treatment Setting- 2015-2022 (USD MM) 
Table 17: United Kingdom Acute Heart Failure Sales- 2015-2022 (USD MM) 
Table 18: AHF United Kingdom Therapy Sales by Treatment Setting- 2015-2022 (USD MM)
Table 19: Japan Acute Heart Failure Sales- 2015-2022 (USD MM) 
Table 20: AHF Japan Therapy Sales by Treatment Setting- 2015-2022 (USD MM) 
Table 21: Side Effects associated with Emerging Therapies (Phase III & Phase II) 
Table 22: Global Market Size of Acute Heart Failure by Country 
Table 23: Global Acute Heart Failure Sales by Therapy 
Table 24: Acute Heart Failure Therapy- Dosage, Days of Therapy and Compliance 
Table 25: Pricing Sources & Assumptions

List of Figures 

Figure 1: Normotensive AHF (SBP 90-140 mmHg) 
Figure 2: Hypotensive AHF (SBP140mmHg) 
Figure 4:Diagnosed Hospitalization Cases of Acute Heart Failure in 7 MM-(2015-2022) 
Figure 5: Total Hospitalization Cases and Diagnosed rate for Acute HF (Men and Women ≥45 Years) (2015-2022) 
Figure 4: Carperitide Historical Sales and Forecasted Sales (2015-2022) (USD MM) 
Figure 1: Global Acute Heart Failure Sales- 2015-2022 (USD MM) 
Figure 2: AHF Global Sales by Treatment Setting- 2015-2022 
Figure 9: AHF Total Therapy Sales by Treatment Setting- 2015-2022 (USD MM) 
Figure 3: United States Acute Heart Failure Sales- 2015-2022 (USD MM) 
Figure 4: AHF United States Sales by Treatment Setting- 2015-2022 (USD MM) 
Figure 5: AHF United States Sales Patient Share by Treatment Setting- 2015-2022 (%) 
Figure 6: France Acute Heart Failure Sales- 2015-2022 (USD MM) 
Figure 7: AHF France Sales by Treatment Setting- 2015-2022 (USD MM) 
Figure 8: AHF France Sales Patient Share by Treatment Setting- 2015-2022 (%) 
Figure 9: Germany Acute Heart Failure Sales- 2015-2022 (USD MM) 
Figure 10: AHF Germany Sales by Treatment Setting- 2015-2022 (USD MM) 
Figure 11: AHF Germany Sales Patient Share by Treatment Setting- 2015-2022 (%) 
Figure 12: Italy Acute Heart Failure Sales- 2015-2022 (USD MM) 
Figure 13: AHF Italy Sales by Treatment Setting- 2015-2022 (USD MM) 
Figure 14: AHF Italy Sales Patient Share by Treatment Setting- 2015-2022 (%) 
Figure 15: Spain Acute Heart Failure Sales- 2015-2022 (USD MM) 
Figure 16: AHF Spain Sales by Treatment Setting- 2015-2022 (USD MM) 
Figure 17: AHF Spain Sales Patient Share by Treatment Setting- 2015-2022 (%) 
Figure 18: United Kingdom Acute Heart Failure Sales- 2015-2022 (USD MM) 
Figure 19: AHF United Kingdom Sales by Treatment Setting- 2015-2022 (USD MM) 
Figure 20: AHF United Kingdom Sales Patient Share by Treatment Setting- 2015-2022 (%) 
Figure 21: Japan Acute Heart Failure Sales- 2015-2022 (USD MM) 
Figure 22: AHF Japan Sales by Treatment Setting- 2015-2022 (USD MM) 
Figure 23: AHF Japan Sales Patient Share by Treatment Setting- 2015-2022 (%) 
Figure 28: Pipeline Trend in Acute Heart Failure

Buy Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=476531

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: 
https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.